This funding round was led by Casdin Capital, which was joined by Vensana Capital, PFM Health Sciences, Twine Ventures, Upside Partnership, and Operator Partners as well as a number of notable individual investors. Apella's initial products include sensors installed in the operating room and harnesses a variety of artificial intelligence approaches to collect and analyze new data about surgery. And this data contributes to applications targeted at improving hospital operations, surgical quality, staff training and real-time decision making with the overall goal of improving the quality of surgical care. The funding round will support expanded implementation of Apella's technology with hospital partners. And it will also allow Apella to grow its team and develop new applications based on its core platform and computer vision and machine learning capabilities.

"Apella believes that every patient deserves the best possible outcome from surgery," commented David Schummers, co-founder and CEO of Apella. "Our technology is aimed at helping each member of the surgical team to do their best job." Apella's initial products include sensors installed in the operating room and harness a variety of artificial intelligence approaches to collect and analyze new data about surgery. This data contributes to applications targeted at improving hospital operations, surgical quality, staff training and real-time decision making with the overall goal of improving the quality of surgical care. "At Apella, we know that you can't improve what you can't measure," continued Schummers.